EA200400356A1 - APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES - Google Patents

APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Info

Publication number
EA200400356A1
EA200400356A1 EA200400356A EA200400356A EA200400356A1 EA 200400356 A1 EA200400356 A1 EA 200400356A1 EA 200400356 A EA200400356 A EA 200400356A EA 200400356 A EA200400356 A EA 200400356A EA 200400356 A1 EA200400356 A1 EA 200400356A1
Authority
EA
Eurasian Patent Office
Prior art keywords
adrenoreceptor agonists
treatment
application
neurodegenerative diseases
nerve cells
Prior art date
Application number
EA200400356A
Other languages
Russian (ru)
Inventor
Йозеф Кригльштейн
Карстен Кульмзее
Вера Юнкер
Хельмут Блум
Вольфганг Греб
Original Assignee
Юкро Юропиан Контракт Рисерч Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10142175A external-priority patent/DE10142175A1/en
Priority claimed from DE10142178A external-priority patent/DE10142178A1/en
Priority claimed from DE10142176A external-priority patent/DE10142176A1/en
Priority claimed from DE10149611A external-priority patent/DE10149611A1/en
Application filed by Юкро Юропиан Контракт Рисерч Гмбх Унд Ко. Кг filed Critical Юкро Юропиан Контракт Рисерч Гмбх Унд Ко. Кг
Priority claimed from PCT/EP2002/009369 external-priority patent/WO2003020257A2/en
Publication of EA200400356A1 publication Critical patent/EA200400356A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Заявлено применение агонистов β-адренорецепторов для восстановления и/или поддержания функции частично или полностью поврежденных/дегенерированных клеток в центральной нервной системе и/или других нервных клеток. Применение агонистов β2-адренорецепторов приводит к активации астроцитов и инициации эндогенных процессов нейрозащиты, причем оно может таким образом уменьшать и в некоторых случаях даже предупреждать повреждение или деструкцию нервных клеток.Отчет о международном поиске был опубликован 2004.01.08.The use of β-adrenoreceptor agonists is claimed to restore and / or maintain the function of partially or fully damaged / degenerated cells in the central nervous system and / or other nerve cells. The use of β2-adrenoreceptor agonists leads to the activation of astrocytes and the initiation of endogenous processes of neuroprotection, and it can thus reduce and in some cases even prevent damage to or destruction of nerve cells. The international search report was published 2004.01.08.

EA200400356A 2001-08-29 2002-08-22 APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES EA200400356A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE10142175A DE10142175A1 (en) 2001-10-09 2001-08-29 Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases
DE10142178A DE10142178A1 (en) 2001-08-29 2001-08-29 Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases
DE10142176A DE10142176A1 (en) 2001-08-29 2001-08-29 Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases
DE10149611A DE10149611A1 (en) 2001-08-29 2001-10-09 Use of beta-adrenoceptor agonists, e.g. reproterol, salmeterol or terbutaline, for restoring and/or maintaining function of damaged nerve cells, e.g. for treatment of neurodegenerative diseases
PCT/EP2002/009369 WO2003020257A2 (en) 2001-08-29 2002-08-22 USE OF β-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Publications (1)

Publication Number Publication Date
EA200400356A1 true EA200400356A1 (en) 2004-08-26

Family

ID=40863263

Family Applications (2)

Application Number Title Priority Date Filing Date
EA200800101A EA200800101A1 (en) 2001-08-29 2002-08-22 APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
EA200400356A EA200400356A1 (en) 2001-08-29 2002-08-22 APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA200800101A EA200800101A1 (en) 2001-08-29 2002-08-22 APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

Country Status (1)

Country Link
EA (2) EA200800101A1 (en)

Also Published As

Publication number Publication date
EA200800101A1 (en) 2008-06-30

Similar Documents

Publication Publication Date Title
HK1091112A1 (en) Compounds and methods for increasing neurogenesis
EA200100575A1 (en) COMPOUNDS OF QUINOLINE AND QUINOXALINE
ATE353640T1 (en) ANTAGONISTS FOR THE TREATMENT OF CD11/CD18 ADHESION RECEPTOR-MEDIATED DISEASES
DK1442058T3 (en) Peptides effective for treating tumors and other conditions requiring cell removal or destruction
EA199901063A1 (en) PIPERAZINE DERIVATIVES AND THEIR APPLICATION AS ANTI-INFLAMMATORY AGENTS
EA200500856A1 (en) NEW CHEMICAL COMPOUNDS
BG104392A (en) Methods for the modulation of serin/treonin protein kinase function with compounds based on 5-azaquinoxaline
BR9712086A (en) Metalloproteinase1,4-heterocyclic inhibitors
ATE280826T1 (en) CC CHEMOKINCEPTOR C-C CKR-5, DERIVATIVES THEREOF AND USES
ATE255896T1 (en) TETRAHYDROPTERIDINE AND PYRIDYLPIPERAZINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
DE69521620T2 (en) USE OF 9-DEOXYPROSTAGLAND IN DERIVATIVES FOR TREATING GLAUCOMA
ES2186796T3 (en) PROCEDURE FOR THE TREATMENT OF ALLERGIC ASTHMA.
ATE277929T1 (en) IMMUNOSUPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES
EA200500849A1 (en) NEW CONNECTIONS LAPAKHONA AND METHODS OF THEIR APPLICATION
SE9303788L (en) Biomedical electrode
ATE237680T1 (en) TRANSPLANTATION OF HEMATOPOIETIC CELLS
ES2196320T3 (en) STABLE POLYHALOPHOSPHACENE SOLUTIONS AGAINST GELATION.
EA200000741A1 (en) NEW DIHYDROXYGEXANE ACID DERIVATIVES
BR9914848A (en) Composition and process for the treatment of disorders of the external retina
CA2251132A1 (en) Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
EA200400356A1 (en) APPLICATION OF β-ADRENORECEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
DE69808475D1 (en) AMINO ACID DERIVATIVES FOR TREATING STROKE
DK0918455T3 (en) Use of galanin for nerve damage repair
EA199900755A1 (en) DERIVATIVE QUINOLIN-2-CARBONIC ACID AND ITS APPLICATION AS AN ANTAGONIST OF EXCESSING AMINO ACIDS
MX9302924A (en) CATARACT TREATMENT AGENT AND METHOD FOR ITS PREPARATION.